Francois Lebel
CIK 1038704 · Chief Medical Officer · last filed 2022-06-23
Francois Lebel is a Chief Medical Officer who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for SPPI, was dated Jun 23, 2022. Across all open-market trades the lifetime net is −$941.1K, making them a net seller over the disclosed history. 16 SEC filings were submitted jointly with SPECTRUM PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZIOP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ARDEN HILLS, MN 55126-2998
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Chief Medical Officer | 652,016 | $1.03 | $671.6K | -$435.1K | 15 | 2022-06-23 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Executive Vice President R&D | 222,233 | $0.87 | $192.4K | -$506.0K | 4 | 2018-01-03 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-23 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Mixed | +392,277 | -$10.5K | EDGAR |
| 2022-04-05 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −2,572 | -$3.6K | EDGAR |
| 2022-03-16 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −50,235 | -$35.4K | EDGAR |
| 2022-02-24 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −28,174 | -$18.9K | EDGAR |
| 2021-11-10 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −13,363 | -$29.3K | EDGAR |
| 2021-06-23 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −10,821 | -$43.8K | EDGAR |
| 2021-04-06 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −2,150 | -$7.0K | EDGAR |
| 2021-03-17 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −41,459 | -$151.5K | EDGAR |
| 2021-02-24 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +110,309 | $0 | EDGAR |
| 2020-11-09 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −12,025 | -$42.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.